Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment
Huntington’s disease (HD) is a neurodegenerative disorder caused by the expansion of CAG repeats in the huntingtin gene. The disease causes the progressive degeneration of neurons affecting particularly the medium spiny neurons (MSNs) within the striatum. The mHtt inclusions promote neurodegeneratio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/80659 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment
- Mechanism of Action of NestaCell®: A Bioinformatics-Guided Translational Approach for Therapeutic Modulation in Huntington’s Disease
- Brain-Derived Neurotrophic Factor and Stem Cell-Based Technologies in Huntington’s Disease Therapy
- Cellular Therapies for Huntington’s Disease
- Stem Cells from Dental Pulp of Deciduous Teeth: Twenty Years of Experience
- Pharma Intelligence Applied to the Research and Development of Cell and Cell-Free Therapy: A New Era of the Medicine
- Use of Antisense Oligonucleotides as Therapy for Huntington's Disease